Harrow acquires global rights to Tyrvaya
Harrow has acquired the global rights to Tyrvaya from Viatris in a deal worth up to $100 million, according to…
FDA approves Lytenava for wet AMD
The FDA approved Lytenava for the treatment of neovascular age-related macular degeneration, according to a press release from Outlook Therapeutics.…
Noninvasive bioelectric therapy for dry AMD begins pivotal study
A pivotal trial is now underway for i-Lumen AMD, a bioelectric therapy being investigated for intermediate to advanced dry age-related…
Noninvasive bioelectric therapy for dry AMD begins pivotal study
A pivotal trial is now underway for i-Lumen AMD, a bioelectric therapy being investigated for intermediate to advanced dry age-related…
Robots will enhance surgery, not replace humans
Click here to read the Healio Exclusive, “Embrace the future’ of robotics in ophthalmology.”I wrote an earlier perspective on the…
Refractive surgery embraces era of corneal preservation
While laser-based procedures continue to deliver excellent refractive outcomes in appropriate candidates, we now better understand the cumulative impact of…
‘Embrace the future’ of robotics in ophthalmology
Click here to read the At Issue to this Healio Exclusive.When new technology is developed, even one that seems revolutionary…
General public unaware of prevalence, impact of dry eye disease
WASHINGTON — The general population may not be as educated about the prevalence of dry eye disease or its impact…
Study shows slower reading, fixation alterations in glaucoma
Patients with glaucoma displayed impaired reading performance and increased saccades, according to a cross-sectional study published in Journal of Glaucoma.“The…
Additive keratoplasty provides noninvasive option for keratoconus
KIAWAH ISLAND, S.C. — In this video from Kiawah Eye & Retina, Beeran B. Meghpara, MD, highlights the benefits of…
Microperimetry helps track structure, function in GA
LAS VEGAS — Customized microperimetry helped researchers track geographic atrophy in patients undergoing CTx001 gene therapy, according to a presentation…
Dompé evaluating intranasal spray for NAION in phase 3 study
The first patient has been enrolled in the phase 3 Galassia-NAION-301 study to evaluate an intranasal spray for the treatment…
All ophthalmologists should help address global visual impairment
The WHO 2019 report on vision estimates that 36 million people in the world are blind and another 217 million…
Healio AI, ASCRS partner to expand ophthalmology learning
Healio AI and the American Society of Cataract and Refractive Surgery, or ASCRS, announced a partnership to optimize available educational…
Changes, challenges abound in eye care in developing nations
Click here to read the Point/Counter to this Cover Story.Through the combined efforts of local governments, pioneering institutions, global health…